Pell Bio-Med Technology Co., Ltd.
6949
Rank in Stocks
#6322
Pell Bio-Med Technology Co., Ltd., established in 2017 and headquartered in... Pell Bio-Med Technology Co., Ltd., established in 2017 and headquartered in Taipei, Taiwan, operates as a biomedical firm specializing in advanced cell culture technologies and methods for therapeutic applications. The company's commercial portfolio encompasses good tissue practice (GTP) laboratory infrastructure, adipose-derived stem cells (ADSC) utilized in regenerative medicine, and both CIK and DC-CIK therapies aimed at combating various cancers. Beyond its existing products, Pell Bio-Med is actively engaged in developing novel pharmaceuticals for diverse cancer types, pioneering cell immunotherapy strategies, and advancing stem cell regenerative therapy techniques. Its research and development efforts extend to cutting-edge areas such as chimeric antigen receptor T cell (CAR-T), CAR-NK, CAR-?dT, and genetically modified ADSC technologies. The company is also progressing product development specifically targeting indications like B-cell non-Hodgkin lymphoma (B-NHL), ovarian cancer, multiple myeloma, and thyroid cancer.
Share Price
$1.37
Last synced: 2026-11-13
Market Cap
$1.79B
Change (1 day)
9.67%
Change (1 year)
-88.92%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Pell Bio-Med Technology Co., Ltd. (6949)
Category
Healthcare
EPS for Pell Bio-Med Technology Co., Ltd. (6949)
EPS as of September 2026 TTM: $-0.01
According to Pell Bio-Med Technology Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.01, equal to its 2024 EPS of $-0.01.
EPS history for Pell Bio-Med Technology Co., Ltd. from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | 0.00% |
| 2025 | $-0.01 | 10.58% |
| 2024 | $-0.01 | -25.71% |
| 2023 | $-0.01 | 45.83% |
| 2022 | $-0.01 | -5.88% |
| 2021 | $-0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 8,800.00% |
US
|
|
| $15.66 | -156,700.00% |
US
|
|
| $-7.07 | 70,600.00% |
US
|
|
| $-5.29 | 52,800.00% |
AU
|
|
| $12.73 | -127,422.00% |
BE
|
Questions about Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS)
What is Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS)?
Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Sep 2026.
What was Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2024.
How has Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS) was highest in 2025 ($-0.01) and lowest in 2025 ($-0.01).
How does Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Pell Bio-Med Technology Co., Ltd.'s earnings per share (EPS) ($-0.01) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.